Form 4: Marimed Director David R. Allen Granted 75,000 Restricted Stock Units

Marimed Inc. Director and 10% Owner, David R. Allen, was granted 75,000 Restricted Stock Units (RSUs) as part of the company's director compensation program.

Summary

• David R. Allen, a Director and 10% Owner of Marimed Inc. (MRMD), received a grant of 75,000 Restricted Stock Units (RSUs).
• The transaction date for this grant was June 12, 2025.
• These RSUs convert to shares of common stock on a one-for-one basis.
• The RSUs were granted as part of Marimed's director compensation program.
• The granted RSUs will vest in full on the one-year anniversary of the grant date, which is June 12, 2026.
• Following this transaction, David R. Allen directly beneficially owns 299,755 shares of common stock and 75,000 Restricted Stock Units.

Sentiment

Score: 6

Explanation: The sentiment is moderately positive as the RSU grant aligns the director's interests with shareholders and is a standard compensation practice, indicating stable corporate governance.

Positives

• The grant of Restricted Stock Units to a director aligns their interests with those of the shareholders, as the value of the compensation is tied to the company's stock performance.
• This transaction is part of a standard director compensation program, indicating established corporate governance practices.

Future Outlook

The 75,000 Restricted Stock Units granted to David R. Allen are scheduled to vest in full on June 12, 2026, which is the one-year anniversary of the grant date.

Management Comments

• The RSUs were granted to the Reporting Person as part of the Issuer's director compensation program.
• The RSUs vest in full on the one-year anniversary of the June 12, 2025 grant date, in accordance with the terms of the award agreement between the Issuer and the Reporting Person.

Industry Context

This Form 4 filing is a routine disclosure of an insider transaction, specifically an equity grant to a director, which is a common practice across various industries for executive and director compensation.

Corporate Governance

Related Party Transactions

• The grant of Restricted Stock Units to David R. Allen, a Director and 10% Owner, constitutes a related party transaction as it involves compensation provided by the company to a key insider.

Stakeholder Impact

• Shareholders: Potential for minor future dilution upon RSU vesting, but also increased alignment of director's interests with shareholder value.
• David R. Allen (Director): Receives equity-based compensation, incentivizing long-term performance and retention.

Next Steps

• The 75,000 Restricted Stock Units are expected to vest on June 12, 2026.

Key Dates

Keywords

Marimed Inc., MRMD, SEC Form 4, Insider Transaction, Restricted Stock Units, RSU, Director Compensation, David R. Allen, Equity Grant